These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11703582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.
    Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M, Takeda T.
    Biochem J; 1991 Oct 15; 279 ( Pt 2)(Pt 2):427-33. PubMed ID: 1683229
    [Abstract] [Full Text] [Related]

  • 8. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis.
    Higuchi K, Naiki H, Kitagawa K, Hosokawa M, Takeda T.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 Oct 15; 60(4):231-8. PubMed ID: 1681611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice.
    Sawashita J, Zhang B, Hasegawa K, Mori M, Naiki H, Kametani F, Higuchi K.
    Proc Natl Acad Sci U S A; 2015 Feb 24; 112(8):E836-45. PubMed ID: 25675489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I.
    Persey MR, Booth DR, Booth SE, van Zyl-Smit R, Adams BK, Fattaar AB, Tennent GA, Hawkins PN, Pepys MB.
    Kidney Int; 1998 Feb 24; 53(2):276-81. PubMed ID: 9461086
    [Abstract] [Full Text] [Related]

  • 16. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family.
    Valleix S, Drunat S, Philit JB, Adoue D, Piette JC, Droz D, MacGregor B, Canet D, Delpech M, Grateau G.
    Kidney Int; 2002 Mar 24; 61(3):907-12. PubMed ID: 11849445
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Accumulation of pro-apolipoprotein A-II in mouse senile amyloid fibrils.
    Higuchi K, Kogishi K, Wang J, Xia C, Chiba T, Matsushita T, Hosokawa M.
    Biochem J; 1997 Aug 01; 325 ( Pt 3)(Pt 3):653-9. PubMed ID: 9271085
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.